Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Other financing activities: 2022-2023

  • Praxis Precision Medicines' Other financing activities fell 4213.76% to -$4.5 million in Q3 2023 from the same period last year, while for Sep 2023 it was $371,000, marking a year-over-year change of. This contributed to the annual value of $262,000 for FY2022, which is 54.43% down from last year.
  • Latest data reveals that Praxis Precision Medicines reported Other financing activities of -$4.5 million as of Q3 2023, which was down 200.00% from $4.5 million recorded in Q2 2023.
  • Praxis Precision Medicines' Other financing activities' 5-year high stood at $4.5 million during Q2 2023, with a 5-year trough of -$4.5 million in Q3 2023.
  • Its 2-year average for Other financing activities is $92,750, with a median of $185,500 in 2022.
  • Data for Praxis Precision Medicines' Other financing activities shows a maximum YoY crashed of 4,213.76% (in 2023) over the last 5 years.
  • Over the past 2 years, Praxis Precision Medicines' Other financing activities (Quarterly) stood at $109,000 in 2022, then crashed by 4,213.76% to -$4.5 million in 2023.
  • Its Other financing activities stands at -$4.5 million for Q3 2023, versus $4.5 million for Q2 2023 and $109,000 for Q3 2022.